Effects of sydnocarb and D-amphetamine on the extracellular levels of amino acids in the rat caudate-putamen.

[1]  S. Oja,et al.  Modulation of taurine release by glutamate receptors and nitric oxide , 2000, Progress in Neurobiology.

[2]  M. Wolf,et al.  Amphetamine Increases Glutamate Efflux in the Rat Ventral Tegmental Area by a Mechanism Involving Glutamate Transporters and Reactive Oxygen Species , 2000, Journal of neurochemistry.

[3]  K. Rayevsky,et al.  Effect of d‐Amphetamine and Sydnocarb on the Extracellular Level of Dopamine, 3,4‐Dihydroxyphenylacetic Acid, and Hydroxyl Radicals Generation in Rat Striatum , 2000, Annals of the New York Academy of Sciences.

[4]  A. Schousboe,et al.  A Possible Role of Alanine for Ammonia Transfer Between Astrocytes and Glutamatergic Neurons , 2000, Journal of neurochemistry.

[5]  J. McGinty,et al.  Delta opioid receptors regulate calcium-dependent, amphetamine-evoked glutamate levels in the rat striatum: an in vivo microdialysis study , 2000, Brain Research.

[6]  E. Vizi.  Role of high-affinity receptors and membrane transporters in nonsynaptic communication and drug action in the central nervous system. , 2000, Pharmacological reviews.

[7]  B. Yamamoto,et al.  Central administration of methamphetamine synergizes with metabolic inhibition to deplete striatal monoamines. , 2000, The Journal of pharmacology and experimental therapeutics.

[8]  M. Wolf,et al.  Amphetamine‐Induced Glutamate Efflux in the Rat Ventral Tegmental Area Is Prevented by MK‐801, SCH 23390, and Ibotenic Acid Lesions of the Prefrontal Cortex , 1999, Journal of neurochemistry.

[9]  F. Mora,et al.  Amphetamine increases the extracellular concentration of glutamate in striatum of the awake rat: involvement of high affinity transporter mechanisms , 1999, Neuropharmacology.

[10]  G. Bustos,et al.  Differential regulation of glutamate, aspartate and γ-amino-butyrate release by N-methyl-d-aspartate receptors in rat striatum after partial and extensive lesions to the nigro-striatal dopamine pathway , 1999, Neurochemistry International.

[11]  K. Vrana,et al.  Cytotoxic and genotoxic potential of dopamine , 1999, Journal of neuroscience research.

[12]  T. Shippenberg,et al.  Behavioral, toxic, and neurochemical effects of sydnocarb, a novel psychomotor stimulant: comparisons with methamphetamine. , 1999, The Journal of pharmacology and experimental therapeutics.

[13]  M. LaVoie,et al.  Dopamine Quinone Formation and Protein Modification Associated with the Striatal Neurotoxicity of Methamphetamine: Evidence against a Role for Extracellular Dopamine , 1999, The Journal of Neuroscience.

[14]  E. Abercrombie,et al.  Enhanced acetylcholine release in striatum after chronic amphetamine is NMDA-dependent. , 1999, Neuroreport.

[15]  B. Yamamoto,et al.  Substrates of Energy Metabolism Attenuate Methamphetamine‐Induced Neurotoxicity in Striatum , 1998, Journal of neurochemistry.

[16]  A. Volterra,et al.  Glutamate transporters are oxidant-vulnerable: a molecular link between oxidative and excitotoxic neurodegeneration? , 1998, Trends in pharmacological sciences.

[17]  M. Colado,et al.  Role of hyperthermia in the protective action of clomethiazole against MDMA (‘ecstasy’)‐induced neurodegeneration, comparison with the novel NMDA channel blocker AR‐R15896AR , 1998, British journal of pharmacology.

[18]  C. Cepeda,et al.  Dopamine and N-Methyl-D- Aspartate Receptor Interactions in the Neostriatum , 1998, Developmental Neuroscience.

[19]  J. Cadet,et al.  Invited Review Free radicals and the pathobiology of brain dopamine systems , 1998, Neurochemistry International.

[20]  M. Wolf,et al.  Amphetamine and D1 Dopamine Receptor Agonists Produce Biphasic Effects on Glutamate Efflux in Rat Ventral Tegmental Area: Modification by Repeated Amphetamine Administration , 1998, Journal of neurochemistry.

[21]  T. Sotnikova,et al.  Effects of a psychostimulant drug sydnocarb on rat brain dopaminergic transmission in vivo. , 1997, European journal of pharmacology.

[22]  S. Berger,et al.  Cocaine and amphetamine preferentially stimulate glutamate release in the limbic system: Studies on the involvement of dopamine , 1997, Synapse.

[23]  S. Oja,et al.  Enhanced taurine release in cell-damaging conditions in the developing and ageing mouse hippocampus , 1997, Neuroscience.

[24]  E. Abercrombie,et al.  Effects of MK-801 on spontaneous and amphetamine-stimulated dopamine release in striatum measured with in vivo microdialysis in awake rats , 1996, Brain Research Bulletin.

[25]  K. Kendrick,et al.  NMDA and Kainate‐evoked Release of Nitric Oxide and Classical Transmitters in the Rat Striatum: In Vivo Evidence that Nitric Oxide May Play a Neuroprotective Role , 1996, The European journal of neuroscience.

[26]  H. Sontheimer,et al.  Cytokine modulation of glial glutamate uptake: a possble involvement of nitric oxide , 1996, Neuroreport.

[27]  M. A. Moro,et al.  Nitric oxide and peroxynitrite exert distinct effects on mitochondrial respiration which are differentially blocked by glutathione or glucose. , 1996, The Biochemical journal.

[28]  D. S. Albers,et al.  Methamphetamine-induced hyperthermia and dopaminergic neurotoxicity in mice: pharmacological profile of protective and nonprotective agents. , 1995, The Journal of pharmacology and experimental therapeutics.

[29]  P. Sonsalla.  The role of N-methyl-D-aspartate receptors in dopaminergic neuropathology produced by the amphetamines. , 1995, Drug and alcohol dependence.

[30]  L. Seiden,et al.  Role of hypothermia in the mechanism of protection against serotonergic toxicity. II. Experiments with methamphetamine, p-chloroamphetamine, fenfluramine, dizocilpine and dextromethorphan. , 1995, The Journal of pharmacology and experimental therapeutics.

[31]  G. Zeevalk,et al.  NMDA Receptor Involvement in Toxicity to Dopamine Neurons In Vitro Caused by the Succinate Dehydrogenase Inhibitor 3‐Nitropropionic Acid , 1995, Journal of neurochemistry.

[32]  A. Volterra,et al.  Glutamate uptake is inhibited by arachidonic acid and oxygen radicals via two distinct and additive mechanisms. , 1994, Molecular pharmacology.

[33]  D. Choi,et al.  Neuroprotective Effect of Hypothermia in Cortical Cultures Exposed to Oxygen‐Glucose Deprivation or Excitatory Amino Acids , 1994, Journal of neurochemistry.

[34]  W. Slikker,et al.  Low environmental temperatures or pharmacologic agents that produce hypothermia decrease methamphetamine neurotoxicity in mice , 1994, Brain Research.

[35]  J. O'Callaghan,et al.  Environment-, drug- and stress-induced alterations in body temperature affect the neurotoxicity of substituted amphetamines in the C57BL/6J mouse. , 1994, The Journal of pharmacology and experimental therapeutics.

[36]  B. Yamamoto,et al.  Methamphetamine‐induced neurotoxicity: Roles for glutamate and dopamine efflux , 1994, Synapse.

[37]  J. Langston,et al.  Rapid ATP Loss Caused by Methamphetamine in the Mouse Striatum: Relationship Between Energy Impairment and Dopaminergic Neurotoxicity , 1994, Journal of neurochemistry.

[38]  S. O'dell,et al.  Excitotoxic striatal lesions protect against subsequent methamphetamine-induced dopamine depletions. , 1994, The Journal of pharmacology and experimental therapeutics.

[39]  S. Moncada,et al.  Reversible inhibition of cytochrome c oxidase, the terminal enzyme of the mitochondrial respiratory chain, by nitric oxide , 1994, FEBS letters.

[40]  T. Ohmori,et al.  Effects of repeated administration of a high dose of methamphetamine on dopamine and glutamate release in rat striatum and nucleus accumbens , 1994, Brain Research.

[41]  W. Slikker,et al.  Further studies of the role of hyperthermia in methamphetamine neurotoxicity. , 1994, The Journal of pharmacology and experimental therapeutics.

[42]  G. Zeevalk,et al.  Hypothermia, Metabolic Stress, and NMDA‐Mediated Excitotoxicity , 1993, Journal of neurochemistry.

[43]  S. O'dell,et al.  Methamphetamine‐Induced Dopamine Overflow and Injury to Striatal Dopamine Terminals: Attenuation by Dopamine D1 or D2 Antagonists , 1993, Journal of neurochemistry.

[44]  M. Colado,et al.  Striatal dopamine release in vivo following neurotoxic doses of methamphetamine and effect of the neuroprotective drugs, chlormethiazole and dizocilpine , 1993, British journal of pharmacology.

[45]  W. Slikker,et al.  Effects of a cold environment or age on methamphetamine-induced dopamine release in the caudate putamen of female rats , 1993, Pharmacology Biochemistry and Behavior.

[46]  J. Townsend,et al.  Pre- and Postsynaptic Neurotoxic Effects of Dopamine Demonstrated by Intrastriatal Injection , 1993, Experimental Neurology.

[47]  G. Zeevalk,et al.  Evidence that the Loss of the Voltage‐Dependent Mg2+ Block at the N‐Methyl‐D‐Aspartate Receptor Underlies Receptor Activation During Inhibition of Neuronal Metabolism , 1992, Journal of neurochemistry.

[48]  S. O'dell,et al.  MK‐801 protection against methamphetamine‐induced striatal dopamine terminal injury is associated with attenuated dopamine overflow , 1992, Synapse.

[49]  B. Yamamoto,et al.  Methamphetamine neurotoxicity and striatal glutamate release: comparison to 3, 4-methylenedioxymethamphetamine , 1992, Brain Research.

[50]  S. Oja,et al.  Release of GABA and taurine from brain slices , 1992, Progress in Neurobiology.

[51]  W. Slikker,et al.  The influence of environmental temperature on the transient effects of methamphetamine on dopamine levels and dopamine release in rat striatum. , 1992, The Journal of pharmacology and experimental therapeutics.

[52]  M. Wolf,et al.  Repeated administration of MK-801 produces sensitization to its own locomotor stimulant effects but blocks sensitization to amphetamine , 1991, Brain Research.

[53]  P. Sonsalla,et al.  Competitive and noncompetitive antagonists at N-methyl-D-aspartate receptors protect against methamphetamine-induced dopaminergic damage in mice. , 1991, The Journal of pharmacology and experimental therapeutics.

[54]  R. Guillery,et al.  Dopamine nerve terminal degeneration produced by high doses of methylamphetamine in the rat brain , 1982, Brain Research.

[55]  J. Gibb,et al.  Long-term effects of multiple doses of methamphetamine on tryptophan hydroxylase and tyrosine hydroxylase activity in rat brain. , 1980, The Journal of pharmacology and experimental therapeutics.

[56]  L. Seiden,et al.  Long-term effects of repeated methylamphetamine administration on dopamine and serotonin neurons in the rat brain: A regional study , 1980, Brain Research.

[57]  L. Seiden,et al.  Long-lasting depletions of striatal dopamine and loss of dopamine uptake sites following repeated administration of methamphetamine , 1980, Brain Research.

[58]  J. Fahrenkrug,et al.  DISTRIBUTION OF VASOACTIVE INTESTINAL POLYPEPTIDE (VIP) IN THE PORCINE CENTRAL NERVOUS SYSTEM , 1978, Journal of neurochemistry.

[59]  H. Fibiger,et al.  Effect of acute and chronic methamphetamine treatment on tyrosine hydroxylase activity in brain and adrenal medulla. , 1971, European journal of pharmacology.

[60]  S. Oja,et al.  Taurine and neural cell damage. , 2000 .

[61]  R. Rockhold.  Glutamatergic involvement in psychomotor stimulant action. , 1998, Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques.